INTERNATIONAL PATENT: HEALTH RESEARCH, INC. FILES APPLICATION FOR "GLP-1R USE DURING IMMUNE CHECKPOINT INHIBITOR TREATMENT FOR NSCLC IN OVERWEIGHT PATIENTS"

GENEVA, Jan. 27 -- HEALTH RESEARCH, INC. (Elm and Carlton StreetsBuffalo, New York 14263) filed a patent application (PCT/US2025/038379) for "GLP-1R USE DURING IMMUNE CHECKPOINT INHIBITOR TREATMENT FOR NSCLC IN OVERWEIGHT PATIENTS" on Jul 19, 2025. With publication no. WO/2026/020163, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): YENDAMURI, Sai (Elm and Carlton StreetsBuffalo, New York 14263), FITZGERALD, Baily (Elm and Carlton StreetsBuffalo, New York 14263)

Abstract: The disclosure relates to a method of treating can...